Role of B Cells and Macrophages in Microvascular Disease After Heart Transplantation[*]

Abstract

Background: The role of B cells and macrophages in microvascular disease after heart transplantation remains controversial. Methods: Out of a total of 809 endomyocardial biopsies without evidence of acute cellular rejection (n = 422, 72 females and 350 males, median age 46 years), 393 without evidence of the quilty phenomenon were investigated zero to ten years after heart transplantation. Vascular reaction (endothelial cell swelling and vessel wall thickening) was graded by H&E staining, and immunohistochemistry was performed for T cells (clone UCHL1), B cells (clone L26) and macrophages (clone KP1) and evaluated semi-quantitatively (light microscopy × 200). Results: Positive reaction for T cells and macrophages as well as evidence of endothelial cell swelling decreased with time after heart transplantation. Positive reactions for B cells were less frequent and increased slightly during the observation time, while vessel wall thickening dominated the last observation interval between the fourth and tenth years. Severity of vascular reaction was independent of immunohistochemical evidence of B cells or macrophages. Conclusions: While activation of the humoral and the non-specific immunological system is common after heart transplantation, microvascular alterations seem to develop independently of these findings.

Key words

Smooth muscle cells - heart transplantation - graft vessel disease - complications - histology

1 Presented at the Annual Meeting of The German Society for Thoracic and Cardiovascular Surgery, Leipzig, February 22 - 26, 2003

References

• 1 Deng M C, Plenz G, Erren M. et al . Transplant vasculopathy: a model for coronary artery disease?.  Herz. 2000;  25 95-99
• 2 Billingham M E. Cardiac transplant atherosclerosis.  Transplant Proc. 1987;  19 19-25
• 3 Hiemann N E, Musci M, Wellnhofer E, Meyer R, Hetzer R. Light microscopic biopsy findings after heart transplantation and possible links to development of graft vessel disease.  Transplant Proc. 1999;  31 149-151
• 4 Hiemann N E, Meyer R, Wellnhofer E, Klimek W J, Bocksch W, Hetzer R. Correlation of angiographic and immunohistochemical findings in graft vessel disease after heart transplantation.  Transplant Proc. 2001;  33 1586-1590
• 5 Ardehali A, Laks H, Drinkwater D C. et al . Expression of major histocompatibility antigens and vascular adhesion molecules on human cardiac allografts preserved in University of Wisconsin solution.  J Heart Lung Transplant. 1993;  12 1044-1051
• 6 Hosenpud J D. Coronary artery disease after heart transplantation and its relation to cytomegalovirus.  Am Heart J. 1999;  138 S469-S472
• 7 Gao H Z, Hunt S A, Alderman E L, Liang D, Yeung A C, Schroeder J S. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease.  J Am Coll Cardiol. 1997;  29 623-629
• 8 Uretsky B F, Murali S, Reddy P S. et al . Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.  Circulation. 1987;  76 827-834
• 9 Winters G L, Kendall T J, Radio S J. et al . Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts.  J Heart Transplant. 1990;  9 364-371
• 10 Billingham M E, Cary N R, Hammond M E. et al . A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.  J Heart Transplant. 1990;  9 587-593
• 11 Joshi A, Masek M A, Brown B W, Weiss L M, Billingham M E. “Quilty” revisited: a 10-year perspective.  Hum Pathol. 1995;  26 547-557
• 12 Naish S J. Handbuch II immunhistochemischer Färbemethoden. Via Real, CA, USA; Dako Corporation 1989
• 13 Akbar A N, Terry L, Timms A, Beverley P C, Janossy G. Loss of CD45 R and gain of UCHL1 reactivity is a feature of primed T cells.  J Immunol. 1988;  140 2171-2178
• 14 Poppema S, Lai R, Visser L. Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity.  Am J Pathol. 1991;  139 725-729
• 15 Pulford K AF, Rigney E M, Micklem K J. et al . KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections.  J Clin Pathol. 1989;  42 414-421
• 16 Hiemann N E, Meyer R, Wellnhofer E, Hetzer R. Correlation of vascular reaction in endomyocardial biopsies with micro- and macrovascular graft vessel disease after heart transplantation.  Graft. 2002;  5 173-178
• 17 Mader A M, Alves M T, Kawakami E, Patricio F R. [Reflux esophagitis in children: histological and morphometric study].  Arq Gastroenterol. 2002;  39 126-131
• 18 Rickenbacher P R, Pinto F J, Lewis N P. et al . Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography.  Am J Cardiol. 1995;  76 340-345
• 19 Keck B M, Bennett L E, Rosendale J, Daily O P, Novick R J, Hosenpud J D. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.  Clin Transpl. 1999;  19 35-49
• 20 Gullestad L, Ross H, Myers J. et al . Importance of decreased heart rate in predicting transplant coronary artery disease.  Clin Transplant. 1997;  11 628-632
• 21 Olivari M T, Homans D C, Wilson R F, Kubo S H, Ring W S. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.  Circulation. 1989;  80 111-115
• 22 Baandrup U, Olsen E G. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects.  Br Heart J. 1981;  45 475-486
• 23 Kavantzas N G, Lazaris A C, Agapitos E V, Nanas J, Davaris P S. Histological assessment of apoptotic cell death in cardiomyopathies.  Pathology. 2000;  32 176-180
• 24 Tracy R E. Medial thickenings of coronary artery and the aging risk factor for atherosclerosis.  Atherosclerosis. 2001;  155 337-346
• 25 Baughman R P, Doers J, Lower E E, Buchsbaum J. Isolation of functionally active pleural macrophages.  J Clin Lab Immunol. 1989;  30 147-151
• 26 Goddard M J, Dunning J, Horsley J, Atkinson C, Pino-Chavez G, Wallwork J. Histopathology of cardiac xenograft rejection in the pig-to-baboon model.  J Heart Lung Transplant. 2002;  21 474-484
• 27 Fyfe A, Daly P, Galligan L, Pirc L, Feindel C, Cardella C. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft.  J Am Coll Cardiol. 1993;  21 171-176
• 28 Holzinger C, Zuckermann A, Reinwald C. et al . Are T cells from healthy heart really only passengers? Characterization of cardiac tissue T cells.  Immunol Lett. 1996;  53 63-67
• 29 Gopal S, Narasimhan U, Day J D. et al . The quilty lesion enigma: focal apoptosis/necrosis and lymphocyte subsets in human cardiac allografts.  Pathol Int. 1998;  48 191-198
• 30 Radio S J, McManus B M, Winters G L. et al . Preferential endocardial residence of B-cells in the “Quilty effect” of human heart allografts: immunohistochemical distinction from rejection.  Mod Pathol. 1991;  4 654-660
• 31 Clausell N, Butany J, Molossi S. et al . Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries.  J Am Coll Cardiol. 1995;  26 110-119
• 32 Hutchinson I V. Cardiac allograft vasculopathy - the cellular attack.  Z Kardiol. 2000;  89 IX/16-20
• 33 Hiemann N E, Meyer R, Musci M, Wellnhofer E, Hetzer R. Prädiktiver Wert des frühen Endothelzellschadens für die Entwicklung einer Transplantatvaskulopathie nach Herztransplantation.  Z Kardiologie. 1998;  87 (Suppl 5) 89
• 34 Knight R J, Dikman S, Liu H, Martinelli G P. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model.  Transplantation. 1997;  64 1102-1107

1 Presented at the Annual Meeting of The German Society for Thoracic and Cardiovascular Surgery, Leipzig, February 22 - 26, 2003